2
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Endocrine
1
CNS
1
Conditions
Breast Neoplasms
118
Neoplasms
110
Lung Neoplasms
65
Colorectal Neoplasms
52
Prostatic Neoplasms
46
Carcinoma, Non-Small-Cell Lung
46
Pancreatic Neoplasms
34
Melanoma
33
Ovarian Neoplasms
29
Neoplastic Cells, Circulating
29
Head and Neck Neoplasms
27
Uterine Cervical Neoplasms
23
Multiple Myeloma
20
Glioma
20
Colonic Neoplasms
20
Carcinoma, Hepatocellular
20
Sarcoma
19
Leukemia, Myeloid, Acute
18
Neoplasm Metastasis
17
Lymphoma
15
Glioblastoma
15
Esophageal Neoplasms
15
Squamous Cell Carcinoma of Head and Neck
14
Hematologic Neoplasms
14
Endometrial Neoplasms
14
Leukemia
13
Myelodysplastic Syndromes
11
Kidney Neoplasms
11
Gastrointestinal Neoplasms
11
Carcinoma, Renal Cell
11
Interventions
3-Iodobenzylguanidine
8
lutetium Lu 177 dotatate
6
gallium Ga 68 dotatate
5
Temozolomide
4
Specimen Handling
4
Magnetic Resonance Spectroscopy
4
anlotinib
3
Everolimus
3
olaparib
2
cabozantinib
2
belzutifan
2
Sunitinib
2
Phenoxybenzamine
2
Nivolumab
2
Fluorodeoxyglucose F18
2
Biopsy
2
Axitinib
2
3-fluorobenzylguanidine
2
177Lu-octreotide, DOTA(0)-Tyr(3)-
2
vandetanib
1
talazoparib
1
spartalizumab
1
pembrolizumab
1
pazopanib
1
lanreotide
1
guadecitabine
1
fluorodopa F 18
1
fludarabine phosphate
1
copper dotatate CU-64
1
cixutumumab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Paraganglioma
×
Blood Specimen Collection
×
Clear all
NCT06444607
2024-11-21
HEPHESTOS
Radboud University Medical Center
Recruiting
200 enrolled